Question 1

What is the catalog number for LEF1 (Lymphoid Enhancer-Binding Factor 1, DKFZp586H0919, TCF1ALPHA) (MaxLight 490)?

Accepted Answer

The catalog number for LEF1 (Lymphoid Enhancer-Binding Factor 1, DKFZp586H0919, TCF1ALPHA) (MaxLight 490) is 248115-ML490.

Question 2

What sizes are available for LEF1 (Lymphoid Enhancer-Binding Factor 1, DKFZp586H0919, TCF1ALPHA) (MaxLight 490)?

Accepted Answer

LEF1 (Lymphoid Enhancer-Binding Factor 1, DKFZp586H0919, TCF1ALPHA) (MaxLight 490) is available in the following size(s): 100 µL.

Question 3

Is LEF1 (Lymphoid Enhancer-Binding Factor 1, DKFZp586H0919, TCF1ALPHA) (MaxLight 490) in stock?

Accepted Answer

LEF1 (Lymphoid Enhancer-Binding Factor 1, DKFZp586H0919, TCF1ALPHA) (MaxLight 490) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 5

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 6

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

LEF1 (Lymphoid Enhancer-Binding Factor 1, DKFZp586H0919, TCF1ALPHA) (MaxLight 490)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Frozen Tissue Sections, Kidney

ACSL5 Recombinant Mouse Monoclonal Antibody [A9D3-R]

MSI1 (NM_002442) Human Over-expression Lysate

DNAAF11 (NM_012472) Human Recombinant Protein

Tissue FFPE Sections, Lung

EPHX2 Human Gene Knockout Kit (CRISPR)